Cathepsins B, K and L are regulated by a defined collagen type II peptide via activation of classical protein kinase C and p38 MAP kinase in articular chondrocytes

Cathepsins B, K and L are regulated by a defined collagen type II peptide via activation of classical protein kinase C and p38 MAP kinase in articular chondrocytes
Ruettger A, Schueler S, Mollenhauer JA, Wiederanders B
J Biol Chem. 2008 Jan 11;283(2):1043-51. Epub 2007 Nov 8. DOI: 10.1074/jbc.M704915200

Degradation of the extracellular matrix (ECM) is a prominent feature in osteoarthritis (OA), which is mainly due to the imbalance between anabolic and catabolic processes in chondrocytes resulting in cartilage and bone destruction. Various proteases act in concert to degrade matrix components, e.g. type II collagen - MMPs, ADAMTS and cathepsins. Protease-generated collagen fragments may foster the destructive process. However, the signaling pathways associated with the action of collagen fragments on chondrocytes have not been clearly defined. The present data demonstrate that the N-terminal telopeptide of collagen type II enhances expression of cathepsins B, K and L in articular chondrocytes at mRNA, protein and activity levels, mediated at least in part through extracellular calcium. We also demonstrate that the induction is associated with the activation of protein kinase C and p38 MAP kinase.